Details for New Drug Application (NDA): 017532
✉ Email this page to a colleague
The generic ingredient in DIABETA is glyburide. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the glyburide profile page.
Summary for 017532
Tradename: | DIABETA |
Applicant: | Sanofi Aventis Us |
Ingredient: | glyburide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 017532
Suppliers and Packaging for NDA: 017532
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIABETA | glyburide | TABLET;ORAL | 017532 | NDA AUTHORIZED GENERIC | TEVA Pharmaceuticals USA Inc | 0093-9364 | 0093-9364-01 | 100 TABLET in 1 BOTTLE (0093-9364-01) |
DIABETA | glyburide | TABLET;ORAL | 017532 | NDA AUTHORIZED GENERIC | TEVA Pharmaceuticals USA Inc | 0093-9364 | 0093-9364-05 | 500 TABLET in 1 BOTTLE (0093-9364-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1.25MG | ||||
Approval Date: | May 1, 1984 | TE: | AB2 | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 1, 1984 | TE: | AB2 | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 1, 1984 | TE: | AB2 | RLD: | Yes |
Expired US Patents for NDA 017532
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-001 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-003 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-001 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-001 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription